KRN Heat Exchanger and Refrigeration Limited has announced a series of investor meetings scheduled from March 17 to March 30, 2026, following a board meeting held on March 13, 2026. The company filed the intimation with stock exchanges BSE and NSE under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Meeting Schedule and Details

The company has outlined the investor engagement schedule in its regulatory filing:

Regulatory Compliance and Disclosures

The management has provided specific clarifications regarding the investor meetings. The company stated that no unpublished price sensitive information will be shared during these interactions with the investor community. Additionally, the dates of the meetings are subject to change due to exigencies on the part of either investors or the company.

Company Information and Contact Details

KRN Heat Exchanger and Refrigeration Limited operates from its registered and work office located at Plot No. F-46,47,48,49, EPIP, RIICO Industrial Area, Neemrana – 301705, Rajasthan. The company trades on BSE with scrip code 544263 and on NSE with symbol KRN.

Filing and Disclosure

The intimation was signed by Jitendra Kumar Sharma, Company Secretary and Compliance Officer, on March 13, 2026. The company has committed to disclosing the information on its official website at www.krnheatexchanger.com as part of its transparency and disclosure obligations.

KRN Heat Exchanger and Refrigeration Limited has successfully concluded its board meeting on March 13, 2026, approving significant corporate actions including a ₹500.00 crore fundraising through Qualified Institutional Placement (QIP), key director reappointments, and scheduling an Extraordinary General Meeting. The comprehensive board decisions mark important strategic developments for the heat exchanger and refrigeration equipment manufacturer.

QIP Approval and Fundraising Details

The board has approved raising funds through equity shares for an aggregate amount of up to ₹500.00 crore via QIP, in accordance with the Companies Act 2013 and SEBI ICDR Regulations 2018. The fundraising initiative provides flexibility in execution based on market conditions and regulatory approvals.

Director Reappointments and Leadership Continuity

The board approved the reappointment of two key leadership positions following recommendations from the Nomination and Remuneration Committee and Audit Committee approval. Both reappointments are subject to member approval at the upcoming general meeting.

Chairman and Managing Director Reappointment: Mr. Santosh Kumar Yadav (DIN: 07789940) has been reappointed as Chairman and Managing Director for a five-year term effective May 9, 2026. As a promoter with over 20 years of experience in heat exchanger and refrigeration manufacturing, he provides strategic guidance and mentorship to the board and management.

Whole-time Director Reappointment: Mrs. Anju Devi (DIN: 06858442) has been reappointed as Whole-time Director for a five-year term effective May 9, 2026. She brings expertise in human resources management and plays a key role in company growth and operations.

Extraordinary General Meeting and Regulatory Compliance

The board approved issuing notice for an Extraordinary General Meeting scheduled for April 15, 2026, to be conducted through video conferencing. The EGM will seek member approval for the QIP fundraising and director reappointments.

In compliance with SEBI Prohibition of Insider Trading Regulations 2015, the trading window for company securities remains closed until March 15, 2026. The company has filed the disclosure under Regulation 30 of SEBI LODR Regulations with both stock exchanges.

Strategic Implications and Market Access

The approved QIP structure offers the company access to qualified institutional buyers while maintaining regulatory compliance. The fundraising initiative, combined with leadership continuity through director reappointments, positions the company for sustained growth in the heat exchanger and refrigeration equipment sector. All approvals remain subject to necessary regulatory clearances and member consent at the scheduled EGM.